Granulomatous hepatitis caused by bacillus Calmette-Guerin (BCG) infection after BCG bladder instillation

Gut

Volumn 38, Issue 4, 1996, Pages 616-618

  Leebeek, F W G ^a,c   Ouwendijk, R J Th ^a   Kolk, A H J ^b   Dees, A ^a   Meek, J Ch E ^a   Nienhuis, J E ^a   Dingemans Dumas, A M ^a  

^a IKAZIA HOSPITAL   (Netherlands)

^b ROYAL TROPICAL INSTITUTE   (Netherlands)

^c ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Bacillus Calmette Guerin; Bladder carcinoma; Granulomatous hepatitis; Mycobacterium

Indexed keywords

BCG VACCINE; DNA;

ADULT; ARTICLE; BLADDER CARCINOMA; CANCER IMMUNOTHERAPY; CASE REPORT; GRANULOMATOUS HEPATITIS; HUMAN; LIVER BIOPSY; MALE; PRIORITY JOURNAL;

EID: 0029940618     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.38.4.616     Document Type: Article

References (16)

1. Witjes JA, van der Meijden APM, Debruyne FMJ. Use of intravesical Bacillus Calmette-Guerin in the treatment of superficial transitional cell carcinoma of the bladder: an overview. Urol Int 1990; 45: 129-36.
2. Lamm DL, van der Meijden APM, Morales A, Brosman SA, Catalona WJ, Herr HW, et al. Incidence and treatment of complications of Bacillus Calmette Guerin intravesical therapy in superficial bladder cancer. J Urol 1992; 147: 596-600.
3. Lamm DL. BCG immunotherapy in bladder cancer. In: Rouse SN, ed. Urology annual. Los Altos: Norwalk, Appleton & Lange, 1987: 67-80.
4. Witjes JA, van der Meijden APM, DeBruyne FMJ. Use of intravesical Bacillus Calmette-Guerin in the treatment of superficial transitional cell carcinoma of the bladder: an overview. Urol Int 1940; 45: 129-36.
5. Kolk AHJ, Schuitema ARJ, Kuiper S, van Leeuwen J, Hermans PWM, van Embden JDA, et al. Detection of Mycobacterium tuberculosis in clinical samples using polymerase chain reaction and a nonradioactive detection system. J Clin Microbiol 1992; 30: 2567-75.
6. Kox LFF, Rhienthong D, Medo Miranda A, Udomsantisuk N, Ellis K, van Leeuwen J, et al. A more reliable PCR for detection of Mycobacterium tuberculosis in clinical samples. J Clin Microbiol 1994; 32: 672-8.
7. Boom R, Sol CJA, Salimans MMM, Jansen CL, Wertheim van Dillen PME, van der Noordaa J. Rapid and simple method for purification of nucleic acids. J Clin Microbiol 1990; 28: 495-503.
8. Kolk AHJ, Noordhoek GT, de Leeuw O, Kuijper S, van Embden JDA. Mycobacterium smegmatis strain for the detection of Mycobacterium tuberculosis by PCR used as internal control for inhibition of amplification and for quantitation of bacteria. J Clin Microbiol 1994; 32: 1354-6.
9. Marans HY, Bekirov HM. Granulomatous hepatitis following intravesical Bacillus Calmette-Guerin therapy for bladder carcinoma. J Urol 1987; 137: 111-2.
10. Steg A, Leleu C, Debre B, Boccon-Gibod L, Sicard D. Systemic Bacillus Calmette-Guerin infection, BCG-itis, in patients treated by intravesical Bacillus Calmette-Guerin therapy for bladder cancer. Eur Urol 1989; 16: 161-4.
11. Thompson D, Cumming J. Granulomatous hepatitis following intravesical BCG therapy. Br J Urol 1990; 66: 432-3.
12. Graziani DA, Jacobs D, Lozano RG, Buck RL. A case of granulomatous hepatitis after intravesical Bacillus-Calmette Guerin administration. J Urol 1991; 146: 118-9.
13. Molina JM, Rabian C, D'Agay MF, Modai J. Hypersensitivity systemic reaction following intravesical Bacillus Calmette Guerin: successful treatment with steroids. J Urol 1992; 147: 695-7.
14. Proctor DD, Chopra S, Rubenstein SC, Jokela JA, Uhl L. Mycobacteremia and granulomatous hepatitis following initial intravesical Bacillus Calmette Guerin instillation for bladder carcinoma. Am J Gastroenterol 1993; 88: 1112-5.
15. McParland C, Cotton DJ, Gowda KS, Hoeppner VH, Martin WT, Weckworth PF. Miliary Mycobacterium bovis induced by the intravesical Bacillus Calmette Guerin immunotherapy. Am Rev Respir Dis 1992; 146: 1330-3.
16. Kristjansson M, Green P, Manning HL, Slutsky AM, Brecher SM, von Reyn CF, et al. Molecular confirmation of Bacillus Calmette Guerin as the cause of pulmonary infection following urinary tract instillation. Clin Infect Dis 1993; 17: 228-30.